Fontoura P, Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF
For example, we found reduced numbers and functionality of Paneth cells in parallel to aberrations of the stem cell niche in CD patients and Tnf ARE mice (9, 39)
The answer depends on your treatment duration, dose level, and individual metabolic response, but evidence suggests a structured approach minimizes rebound weight gain
Start Your Journey In 3 Easy Steps Share a few details and your goals
Joshi M, Joshi A, Bartter T
For obesity management, glucagon-like peptide 1 (GLP1) agonists like Zepbound (tirzepatide) and Wegovy (semaglutide) may be safer and more effective, especially when combined with lifestyle changes such as increased physical activity